I analyze the effects of four types of medical innovation and cancer incidence on US cancer mortality rates during the … pre‐dated factors that drove both innovation and mortality and that there would have been parallel trends in mortality in … the absence of innovation, the estimates indicate that there were three major sources of the 13.8% decline of the age …

I assess the impact that pharmaceutical innovation had on cancer mortality in Mexico during the period 2003-2013, by ….) that were subject to more pharmaceutical innovation, controlling for changes in the age-standardized cancer incidence rate … of cancer drug innovation to Mexican longevity growth has been valuable, but, perhaps, it could have been even larger …

This study examines the impact of pharmaceutical innovation and other factors on the survival of U.S. cancer patients … other types of medical innovation, i.e. other pharmaceutical innovation, and innovation in surgical procedures, diagnostic … of rates of innovation in chemotherapy and other treatment and diagnostic procedures are constructed from the MEDSTAT …

We analyze the association that pharmaceutical innovation had with premature mortality from all diseases in Switzerland … 2002-2019. The analysis is performed by investigating whether the diseases that experienced more pharmaceutical innovation … had larger subsequent declines in premature mortality and hospitalization. Pharmaceutical innovation is measured by the …

contribution by Lichtenberg (2004), which relates longevity in the United States to pharmaceutical innovation and public health …